Lung Center of the Philippines | Pulmonary, Critical Care and Sleep Medicine Department

Research site

(Unclaimed)

Location

Quezon Avenue, Quezon City, National Capital Region, Philippines

Site insights

Top conditions

Top treatments

MK-4482

Molnupiravir

TBAJ876

MK-3475

C21

GT0918

Trimodulin

Talactoferrin

Ritonavir

Atezolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 22 total trials

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

This multicenter, two-stage, open-label, randomized trial will aim to assess the efficacy, safety, optimal duration, and pharmacokinetics (PK) of Del...

Active, not recruiting

Pulmonary Tuberculosis

Drug: Isoniazid and Rifampicin (HR)

Drug: Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (HRZE)

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) (ESsCAPE)

The main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to plac...

Enrolling

Community-acquired Pneumonia

Drug: Trimodulin

Drug: Placebo (human albumin 1%)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizum...

Enrolling

Solid Tumors

Hematologic Malignancies

Drug: Pembrolizumab

Drug: Lenvatinib

LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (ELEVATE)

This study a randomized, double-blind, four arm study to evaluate the safety and efficacy of LYT-100 compared to pirfenidone or placebo in adults wit...

Active, not recruiting

Idiopathic Pulmonary Fibrosis

Drug: Deupirfenidone

Drug: Placebo

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TB

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (explores what the body does to the drug), and anti-mycobacterial...

Enrolling

Multidrug-Resistant Tuberculosis

Drug: Bedaquiline (TMC207)

Drug: Background Regimen (BR)

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms